We do not have information on CD4+ count, opportunistic infections, diarrheal disease, ART regimen, timing of ART, ART/CPT drug compliance, and drug adverse effects; these factors may positively/negatively affect TB treatment outcomes. The gene discussed is CD4; the disease is Opportunistic infection.